查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1386381

水產養殖疫苗市場報告：2030 年趨勢、預測與競爭分析

Aquaculture Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

水產養殖疫苗的趨勢與預測

2030年，全球水產養殖疫苗市場預計將達到7億美元，2024年至2030年的年複合成長率為7.6%。該市場的主要促進因素是對水生動物食品的需求增加、水產養殖部門感染疾病的顯著增加以及水產養殖產量的擴大。全球水產養殖疫苗市場前景廣闊，去活化疫苗和DNA疫苗市場蘊藏商機。

水產養殖疫苗市場洞察

Lucintel 廣泛用於水生動物，作為多種疾病的預防措施，包括水腫、弧菌病、冷水弧菌病、冬腐病、IPN 和鮭魚傳染性貧血(ISA)，使其成為一種注射藥物。我們預測它將繼續成為一個更大的細分市場。

亞太地區預計將在預測期內實現最高成長，因為它是該地區最大的水產養殖業之一。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球水產養殖疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球水產養殖疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球水產養殖疫苗市場（按產品）
    • 去活化疫苗
    • DNA疫苗
  • 按給藥途徑分類的全球水產養殖疫苗市場
    • 注射
    • 口服

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球水產養殖疫苗市場區域分佈
  • 北美洲水產養殖疫苗市場
  • 歐洲水產養殖疫苗市場
  • 亞太水產養殖疫苗市場
  • 其他地區水產養殖疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球水產養殖疫苗市場成長機會（按產品）
    • 按給藥途徑分類的全球水產養殖疫苗市場成長機會
    • 全球水產養殖疫苗市場成長機會（按地區）
  • 全球水產養殖疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球水產養殖疫苗市場產能
    • 全球水產養殖疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
  • CSL
  • Emergent BioSolutions
  • Johnson & Johnson
  • AstraZeneca
  • Serum Institute of India
  • Bavarian Nordic
簡介目錄

Aquaculture Vaccine Trends and Forecast

The future of the global aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets. The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.

A more than 150-page report is developed to help in your business decisions.

Aquaculture Vaccine by Segment

The study includes a forecast for the global aquaculture vaccine by product, route of administration, and region.

Aquaculture Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Inactivated Vaccines
  • DNA Vaccines

Aquaculture Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Injected
  • Oral

Aquaculture Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Aquaculture Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies aquaculture vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the aquaculture vaccine companies profiled in this report include-

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
  • CSL
  • Emergent BioSolutions
  • Johnson & Johnson
  • AstraZeneca
  • Serum Institute of India
  • Bavarian Nordic

Aquaculture Vaccine Market Insights

Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).

APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.

Features of the Global Aquaculture Vaccine Market

Market Size Estimates: Aquaculture vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Aquaculture vaccine market size by product, route of administration, and region in terms of value ($B).

Regional Analysis: Aquaculture vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, and regions for the aquaculture vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the aquaculture vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the aquaculture vaccine market size?

Answer: The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030.

Q.2 What is the growth forecast for aquaculture vaccine market?

Answer: The global aquaculture vaccine market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the aquaculture vaccine market?

Answer: The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.

Q4. What are the major segments for aquaculture vaccine market?

Answer: The future of the aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets.

Q5. Who are the key aquaculture vaccine market companies?

Answer: Some of the key aquaculture vaccine companies are as follows:

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
  • CSL
  • Emergent BioSolutions
  • Johnson & Johnson
  • AstraZeneca
  • Serum Institute of India
  • Bavarian Nordic

Q6. Which aquaculture vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).

Q7. In aquaculture vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the aquaculture vaccine market by product (inactivated vaccines and DNA vaccines), route of administration (injected and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Aquaculture Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Aquaculture Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Aquaculture Vaccine Market by Product
    • 3.3.1: Inactivated Vaccines
    • 3.3.2: DNA Vaccines
  • 3.4: Global Aquaculture Vaccine Market by Route of Administration
    • 3.4.1: Injected
    • 3.4.2: Oral

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Aquaculture Vaccine Market by Region
  • 4.2: North American Aquaculture Vaccine Market
    • 4.2.2: North American Aquaculture Vaccine Market by Route of Administration: Injected and Oral
  • 4.3: European Aquaculture Vaccine Market
    • 4.3.1: European Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
    • 4.3.2: European Aquaculture Vaccine Market by Route of Administration: Injected and Oral
  • 4.4: APAC Aquaculture Vaccine Market
    • 4.4.1: APAC Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
    • 4.4.2: APAC Aquaculture Vaccine Market by Route of Administration: Injected and Oral
  • 4.5: ROW Aquaculture Vaccine Market
    • 4.5.1: ROW Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
    • 4.5.2: ROW Aquaculture Vaccine Market by Route of Administration: Injected and Oral

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Aquaculture Vaccine Market by Product
    • 6.1.2: Growth Opportunities for the Global Aquaculture Vaccine Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Aquaculture Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Aquaculture Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Aquaculture Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Aquaculture Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Merck
  • 7.3: Pfizer
  • 7.4: Sanofi
  • 7.5: CSL
  • 7.6: Emergent BioSolutions
  • 7.7: Johnson & Johnson
  • 7.8: AstraZeneca
  • 7.9: Serum Institute of India
  • 7.10: Bavarian Nordic